242 related articles for article (PubMed ID: 33826787)
1. Quinomycin A reduces cyst progression in polycystic kidney disease.
Radadiya PS; Thornton MM; Daniel EA; Idowu JY; Wang W; Magenheimer B; Subramaniam D; Tran PV; Calvet JP; Wallace DP; Sharma M
FASEB J; 2021 May; 35(5):e21533. PubMed ID: 33826787
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
[TBL] [Abstract][Full Text] [Related]
3. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
[TBL] [Abstract][Full Text] [Related]
4. Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease.
Verschuren EHJ; Rigalli JP; Castenmiller C; Rohrbach MU; Bindels RJM; Peters DJM; Arjona FJ; Hoenderop JGJ
FASEB J; 2020 May; 34(5):6382-6398. PubMed ID: 32159259
[TBL] [Abstract][Full Text] [Related]
5. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
[TBL] [Abstract][Full Text] [Related]
7. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
Dwivedi N; Jamadar A; Mathew S; Fields TA; Rao R
Kidney Int; 2023 Jan; 103(1):144-155. PubMed ID: 36273656
[TBL] [Abstract][Full Text] [Related]
8. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
[TBL] [Abstract][Full Text] [Related]
9. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y
Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110
[TBL] [Abstract][Full Text] [Related]
11. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
[TBL] [Abstract][Full Text] [Related]
12. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
13. Pkd1 inactivation induced in adulthood produces focal cystic disease.
Takakura A; Contrino L; Beck AW; Zhou J
J Am Soc Nephrol; 2008 Dec; 19(12):2351-63. PubMed ID: 18776127
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.
Idowu J; Home T; Patel N; Magenheimer B; Tran PV; Maser RL; Ward CJ; Calvet JP; Wallace DP; Sharma M
Sci Rep; 2018 Feb; 8(1):3340. PubMed ID: 29463793
[TBL] [Abstract][Full Text] [Related]
15. Effect of celastrol on the progression of polycystic kidney disease in a Pkd1-deficient mouse model.
Chang MY; Hsieh CY; Lin CY; Chen TD; Yang HY; Chen KH; Hsu HH; Tian YC; Chen YC; Hung CC; Yang CW
Life Sci; 2018 Nov; 212():70-79. PubMed ID: 30268856
[TBL] [Abstract][Full Text] [Related]
16. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
[TBL] [Abstract][Full Text] [Related]
18. Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease.
Parnell SC; Raman A; Zhang Y; Daniel EA; Dai Y; Khanna A; Reif GA; Vivian JL; Fields TA; Wallace DP
Kidney Int; 2022 Nov; 102(5):1103-1114. PubMed ID: 35760151
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease.
Tao S; Kakade VR; Woodgett JR; Pandey P; Suderman ED; Rajagopal M; Rao R
Kidney Int; 2015 Jun; 87(6):1164-75. PubMed ID: 25629553
[TBL] [Abstract][Full Text] [Related]
20. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
